Cormio G, Maneo A, Gabriele A, et al. Primary carcinoma of the fallopian tube: a retrospective analysis of 47 patients. Ann Oncol 1996;7:271–275.
482.
Alvarado-Cabrero I, Young RH, Vamvakas EC, et al. Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factors. Gynecol Oncol 1999;72:367–379.
483.
Podratz KC, Podczaski ES, Gaffey TA, et al. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol 1986;154:1319–1326.
484.
Romagosa C, Torne A, Iglesias X, et al. Carcinoma of the fallopian tube presenting as acute pelvic inﬂammatory disease. Gynecol Oncol 2003;89:181–184.
485.
Kosary C, Trimble EL. Treatment and survival for women with fallopian tube carcinoma: a population-based study. Gynecol Oncol 2002;86:190–191.
486.
Hellstrom AC, Silfversward C, Nilsson B, et al. Carcinoma of the fallopian tube: a clinical and histopathologic review. The Radiumhemmet series. Int J Gynecol Cancer 1994;4:395–407.
487.
Levine DA, Argenta PA, Yee CJ, et al. Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations. Clin Oncol 2003;21:4222–4227.
488.
Mikami M, Tei C, Kurahashi T, et al. Preoperative diagnosis of fallopian tube cancer by imaging. Abdom Imaging 2003;28:743–747.
489.
Barakat RR, Rubin SC, Saigo PE, et al. Cisplatin-based combination chemotherapy in carcinoma of the fallopian tube. Gynecol Oncol 1991;42:156–160.
490.
Cormio G. Experience at the Memorial Sloan-Kettering Cancer Center with paclitaxel-based combination chemotherapy following primary cytoreductive surgery in carcinoma of the fallopian tube. Gynecol Oncol 2002;84:185–186.
491.
Markman M, Zanotti K, Webster K, et al. Phase 2 trial of single agent docetaxel in platinum and paclitaxel-refractory ovarian cancer, fallopian tube cancer, and primary carcinoma of the peritoneum. Gynecol Oncol 2003;91:573–576.
492.
Kuscu E, Oktem M, Haberal A, et al. Management of advanced-stage primary carcinoma of the fallopian tube: case report and literature review. Eur J Gynaecol Oncol 2003;24:557–560.
493.
Matulonis U, Campos S, Duska L, et al. A phase II trial of three sequential doublets for the treatment of advanced mullerian malignancies. Gynecol Oncol 2003;91:293–298.
494.